Venture Global initiated with a Buy at Guggenheim
Guggenheim initiated coverage of Venture Global (VG) with a Buy rating and $27 price target Discover the Best Stocks and Maximize Your ...
Generali’s Investments Have So Far Been Effective and Returns on Equity Have Been Rising Gradually
The business has invested significant amounts in data and technology over recent years and those investments have led to improvements in margins across nonlife. We think in nonlife insurance, versus ...
Parnassus Growth Equity Fund Q4 And 2024 Annual Investment Commentary
The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.
Guggenheim Reaffirms Their Buy Rating on Nike (NKE)
Guggenheim analyst Robert Drbul maintained a Buy rating on Nike (NKE – Research Report) yesterday and set a price target of $110.00. The ...
Guggenheim raises Confluent stock target to $38, maintains buy rating
Guggenheim Securities updated their outlook on Confluent Inc (NASDAQ:CFLT), increasing the price target to $38 from the previous $35, while maintaining a Buy rating on the company's shares. According ...
Guggenheim Reiterates “Buy” Rating for ORIC Pharmaceuticals (NASDAQ:ORIC)
ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.